Χώρα: Μάλτα
Γλώσσα: Αγγλικά
Πηγή: Medicines Authority
Laboratorios Azevedos - Industria Farmaceutica SA Estrada Nacional 117-2 Alfragide, 2614-503 Amadora, Portugal
R05CB06
AMBROXOL HYDROCHLORIDE 30 mg/5ml
SYRUP
AMBROXOL HYDROCHLORIDE 30 mg/5ml
OTC
COUGH AND COLD PREPARATIONS
Licence number in the source country: NOT APPLICAPABLE
Authorised
2023-02-02
PACKAGE LEAFLET: INFORMATION FOR THE USER AMBROXOL TUSSILENE 6 MG/ML, SYRUP AMBROXOL HYDROCHLORIDE Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor, or pharmacist or nurse have told you. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. If you get any side effects, talk to your doctor, or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. You must talk to a doctor if you do not feel better or if you feel worse after 8 days. What is in this leaflet 1. What Ambroxol Tussilene is and what it is used for 2. What you need to know before you take Ambroxol Tussilene 3. How to take Ambroxol Tussilene 4. Possible side effects 5. How to store Ambroxol Tussilene 6. Contents of the pack and other information 1. What Ambroxol Tussilene is and what it is used for Ambroxol Tussilene reduces the viscosity of the bronchial secretions. The mucous becomes more fluid. Ambroxol Tussilene has a stimulating effect over the bronchial mucosa causing the production of more fluid secretions. Moreover, it enhances pulmonary surfactant production of the alveoli and the bronchi and its drainage. Enhances pulmonary surfactant production and stimulates ciliary activity These mechanisms, together with the stimulation of the bronchial epithelial cilia activity, maintain and improve the auto-clearance capacity of the airways. Due to its fluidizing and expectorant action it promotes and accelerated the process of mucous clearance from the alveoli. Adjunctive mucolytic antibacterial treatment of respiratory infections in the presence of bronchial hypersecretion. You must talk to a doctor if you do not feel better or if you feel worse after 8 days. 2. What you need to know before you take Ambroxol Tussilene Do not take Ambroxol Tussilene - if you are allergic to ambroxol or any of the o Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ambroxol Tussilene 6 mg/ml, syrup 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml of syrup contains 30 mg of ambroxol hydrochloride. Excipients with known effect: Sorbitol (E420) – 716 mg/ml (70 % sorbitol solution) Ethanol at 96% - 49.35 mg/ml Propylene glycol (E1520) – 40 mg/ml For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Syrup Colourless clear solution with strawberry-mint flavour 4. CLINICAL PARTICULARS 4.1 Therapeutic Indications Adjuvant mucolytic antibacterial therapy for respiratory infections in the presence of hypersecretion. 4.2 Posology and method of administration Posology 5 ml of syrup = 1 full tea spoon The treatment should not exceed more than 5-7 days without medical advice. Adults and children over 12 years: 10 ml (2 tea spoons), twice a day. This scheme is suitable for the treatment of acute disorders of respiratory tract and for initial treatment of chronic conditions up to 14 days. Pediatric population Treatment for children under 12 years, depending on the severity of the disease, is recommended dosage regimen: Children from 6 to 12 years: 5 ml (1 tea spoon), 2-3 times a day (corresponding to 1,2 mg/Kg of body mass) Children from 2 to 5 years: 2,5 ml (½ tea spoon), 3 times a day (corresponding to 1,25 mg/Kg of body mass) Children from 1 to 2 years: 2,5 ml (½ tea spoon), 2 times a day (corresponding to 1,6 mg/Kg of body mass) These dosages corresponding to the initial treatment; the dosages could be halved after 14 days. Method of administration Ambroxol Tussilene should be taken at meal times. 4.3 Contraindications Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. In case of rare hereditarily conditions that may be incompatible with one of the excipients (see section 4.4). In case of alcoholism, you should be careful with this medicine (see section 4.4). 4.4 Special warnings and precautions for use The recommended maximum daily dose (20 ml) Amb Διαβάστε το πλήρες έγγραφο